국가: 아르메니아
언어: 영어
출처: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
perindopril (perindopril arginine), indapamide
Les Laboratoires Servier Industrie 905
C09BA04
perindopril (perindopril arginine), indapamide
5mg+ 1,25mg
tablets film-coated
(30) in plastic container
Prescription
Registered
2017-11-30
CIS_PIL_PRESTARIUM COMBI Arginine_02.2015 1/7 LEAFLET: INFORMATION FOR THE USER PRESTARIUM ® COMBI ARGININE perindopril arginine/indapamide film-coated tablets READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOT YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their sings of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What PRESTARIUM COMBI Arginine is and what it is used for 2. what you need to know before you take PRESTARIUM COMBI Arginine 3. How to take PRESTARIUM COMBI Arginine 4. Possible side effects 5. How to store PRESTARIUM COMBI Arginine 6. Contents of the pack and other information 1. WHAT PRESTARIUM COMBI ARGININE IS AND WHAT IT IS USED FOR PRESTARIUM COMBI Arginine is a combination of two active ingredients, perindopril and indapamide. It is an anti-hypertensive and is used in the treatment of high blood pressure (hypertension) in adults. Perindopril belongs to a class of medicines called ACE inhibitors. These work by widening the blood vessels, which makes it easier for your heart to pump blood through them. Indapamide is a diuretic. Diuretics increase the amount of urine produced by the kidneys. However, indapamide is different from other diuretics, as it only causes a slight increase in the amount of urine produced. Each of the active ingredients reduces blood pressure and they work together to control your blood pressure. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PRESTARIUM COMBI ARGININE DO NOT TAKE PRESTARIUM COMBI ARGININE - if you are allergic to perindopril or any other ACE inhibitor, or to indapamide or any other sulphonamides or any of the other ingredients of this medicine (listed in section 6), 전체 문서 읽기
SPC_Prestarium Combi arginine_06.2017 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PRESTARIUM ® COMBI Arginine 5mg/1.25mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 3.395mg perindopril corresponding to 5mg perindopril arginine and 1.25mg indapamide. Excipient with know effect: 71.33mg lactose monohydrate For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. White, rod-shaped film-coated tablet. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension in adults, PRESTARIUM COMBI Arginine is indicated in patients whose blood pressure is not adequately controlled on perindopril alone. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology One PRESTARIUM COMBI Arginine film-coated tablet per day as a single dose, preferably to be taken in the morning, and before a meal. When possible individual dose titration with the components is recommended. PRESTARIUM COMBI arginine film-coated tablet should be used when blood pressure is not adequately controlled on NOLIPREL arginine film-coated tablet (when available). When clinically appropriate, direct change from monotherapy to PRESTARIUM COMBI Arginine may be considered. Special populations _ _ _Elderly (see section 4.4) _ Treatment should be initiated after considering blood pressure response and renal function. _Renal impairment (see section 4.4) _ In severe renal impairment (creatinine clearance below 30 ml/min), treatment is contraindicated. In patients with moderate renal impairment (creatinine clearance 30-60 ml/min), it is recommended to start treatment with the adequate dosage of the free combination. In patients with creatinine clearance greater than or equal to 60 ml/min, no dose modification is required. Usual medical follow-up will include frequent monitoring of creatinine and potassium. 2 _Hepatic impairment (see sections 4.3, 4.4 and 5.2) _ In severe hepatic impairment, treatment is contraindicated. In patients with mod 전체 문서 읽기